Discussions reflect a strong interest in understanding ayahuasca's effects, with posts often mentioning the timing of DMT peaks and its mood-enhancing properties, while some explore its potential medical uses; this tone of curiosity and consideration for broader implications underscores the overall impact and engagement.
AgreementModerate agreement
Most discussions acknowledge the validity of the research, highlighting the relevance of the findings on subjective and cardiovascular effects.
InterestHigh interest
Participants display high curiosity, often referencing specific elements like DMT peaks and monoamine metabolites, showing engagement with the study details.
EngagementModerate engagement
Many responses delve into implications, such as the therapeutic potential and physiological mechanisms, indicating a moderate depth of engagement.
ImpactModerate impact
There is a shared recognition that the study could influence future research and clinical applications, though some consider it preliminary.
Abstract in brief
Ayahuasca, a traditional South American brew, contains DMT and harmala alkaloids, which together produce strong psychedelic effects and influence cardiovascular variables in users.
The study found that ayahuasca leads to perceptual changes, improved mood, and increased diastolic blood pressure, with DMT levels peaking about 1.5 hours after ingestion, aligning with its strongest effects.
Despite harmine acting as an MAO inhibitor, urine analysis showed increased monoamine metabolites, suggesting harmine's primary effects occur in the gut and liver, preventing DMT breakdown and enabling it to reach the brain.
This video reviews the history, methods, and recent findings on the endogenous hallucinogen DMT, including its production and breakdown in the brain and body, and explores its potential roles as a neurotransmitter with…
Is ayahuasca actually medicine or just a trendy way to throw up in the jungle? This video explores the science behind its therapeutic effects for depression, anxiety, PTSD, and other mental health conditions, including…
Ayahuasca, a traditional South American brew containing DMT and harmala alkaloids, produces strong psychedelic effects and influences cardiovascular variables. The study highlights perceptual changes, mood improvements…
Medicinal Plant Monograph | PDF | Biology | Plants
News
doi: 10.1124/jpet.103.049882 209-218. Rivier, L., & Lindgren, J.-E. (1972). "Ayahuasca," the South American Hallucinogenic Drink: An Ethnobotanical and Chemical
Ayahuasca Pharmacology, Neuroscience and Therapeutic Potential ...
News
... PET study with [F-18]FDG. Neuropsychopharmacology 20. Andreasen, N ... 73–83, http://dx.doi.org/10.1124/jpet.103.049882. Mazur-Kolecka, B., Golabek ...
Ayahuasca Improves Emotion Dysregulation in A Community ...
News
https://doi.org/10.1124/jpet. Tupper KW (2008) The globalization of ayahuasca: harm reduction or 103.049882 benefit maximization? Int J Drug Policy 19:297 ...
doi:10.1124/jpet.103.049882. PMID 12660312. [28] Verdcourt B (1958). Remarks on the classication of the. Rubiaceae. Bulletin du Jardin botanique de l'tat ...
The Psychedelic Future of PTSD Treatment | PDF | Psychological ...
News
... 10.1124/jpet.107.129056 http://dx.doi.org/10.1093/scan/nst161 [337] Liechti ... 103.049882 properties of the experiences questionnaire: Validation of a ...